Practice Pearls for Physicians Considering CAR T-cell Therapy for Patients with LBCL


Closing out this discussion of post-ASH 2022 perspectives, Matthew Lunning, DO, FACP, shares important clinical practice pearls for physicians considering CAR T-cell therapy for patients with LBCL.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.